NMRA
Neumora Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Neumora Therapeutics (NMRA) Stock: Buy, Sell, or Hold?
$0.46
-0.01 (-1.61%)
▼
5d:
-18.89%
30d:
+24.01%
90d:
-73.46%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (42%)
Quality Score
31/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$0.38 – $0.56
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-0.7x
Next 12M consensus est.
Wall Street Target
$6.00
+1185.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.35 / $0.65
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: NMRA is down 18.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When NMRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NMRA is currently trading at $0.46, which is considered slightly high relative to its 30-day fair value range of $0.38 to $0.56.
Technical Outlook: Technically, NMRA is in a strong downtrend. Immediate support is located at $0.35, while resistance sits at $0.65.
Market Sentiment: NMRA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.00 (+1185.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NMRA is in a strong downtrend. Immediate support is located at $0.35, while resistance sits at $0.65.
Market Sentiment: NMRA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.00 (+1185.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.38 -
$0.56
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
Trading Range & Key Levels
30-Day Trading Range
$0.38 -
$0.56
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$0.35
Resistance Level
$0.65
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1185.9% below Wall St target ($6.00)
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.72
Wall Street Target
$6.00
(+1185.9%)
Share NMRA Analysis
Share this live NMRA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NMRA)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message suggests an unexpected catalyst for $NMRA beyond the three anticipated clinical catalysts, potentially related to Q3 financials.
Key Retail Themes:
financials
clinical catalysts
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:50 AM ET
Data refreshes hourly during market hours. Next update: 10:50 AM
Data refreshes hourly during market hours. Next update: 10:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NMRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 47 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 63 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NMRA Research Pages